BRITTANY BORDONARO: Open Payments
NPI 1548630999 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,482 in 119 payments from 17 companies in 2025. Trend: 2023 $962 · 2024 $1,868 · 2025 $2,482
Food & beverage: $2,389Education: $94
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $396 |
| Ardelyx, Inc. | 15 | $370 |
| Janssen Biotech, Inc. | 14 | $330 |
| Madrigal Pharmaceuticals | 6 | $314 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $181 |
| QOL Medical, LLC | 4 | $161 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $147 |
| PFIZER INC. | 15 | $145 |
| Exact Sciences Corporation | 5 | $92 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
Products named: IBSRELA, TREMFYA, REZDIFFRA, XIFAXAN, SKYRIZI, Sucraid, XELJANZ, RINVOQ.
Industry payments across CT — which companies pay providers there.
